As the craze of earnings season draws to a close, here's a look back at some of the most exciting (and some less so) results from Q1. Today, we are looking at research tools & consumables stocks, ...

Revvity has acquired companies in sectors with high-growth potential, such as cell and gene therapies, and precision medicine, among other sectors. The company has strengthened its debt position, ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Feb 2 (Reuters) - Medical equipment maker ‌Revvity handily beat fourth-quarter estimates ‌and forecast 2026 revenue and profit above Wall Street expectations on Monday, betting on continued strength ...

Revvity, formerly PerkinElmer, has undergone a major transformation over the past decade. Following the 2023 divestiture of its applied, food, and enterprise services business, the firm rebranded as ...

Jan 12 (Reuters) - Revvity (RVTY.N), opens new tab said on Monday it expects its 2025 adjusted profit per share to ‌exceed its forecast of $4.90 to $5, as the medical equipment maker benefits from ...

Revvity launches its first set of IVD Mimix reference standards, providing diagnostic labs with trusted quality controls for optimizing tests and monitoring workflows “Accurate diagnosis, including ...

Revvity, Inc. announced the launch of multiple new discovery platforms and technologies at SLAS2026, which are designed to accelerate high-throughput drug discovery workflows. Making their debut at ...

WALTHAM, Mass.--(BUSINESS WIRE)--Today Revvity, Inc. (NYSE: RVTY), announced the launch of its Living Image™ Synergy AI multimodal analysis software for in vivo imaging researchers. The solution ...

Scientists can now search, understand and act on complex R&D data in natural language by leveraging leading LLM capabilities within the Signals One platform Governed data and ontology-driven ...